Centiva Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
84,187
+60,031
| +249% | +$1.01M | 0.02% | 274 |
|
|
2025
Q1 | $371K | Buy |
+24,156
| New | +$371K | 0.01% | 804 |
|
|
2024
Q4 | – | Sell |
-50,037
| Closed | -$902K | – | 1828 |
|
|
2024
Q3 | $902K | Buy |
50,037
+1,514
| +3% | +$27.3K | 0.02% | 541 |
|
|
2024
Q2 | $788K | Buy |
48,523
+17,966
| +59% | +$292K | 0.01% | 588 |
|
|
2024
Q1 | $431K | Buy |
+30,557
| New | +$431K | 0.01% | 768 |
|
|
2023
Q3 | – | Sell |
-28,830
| Closed | -$217K | – | 1567 |
|
|
2023
Q2 | $217K | Buy |
28,830
+27,998
| +3,365% | +$211K | ﹤0.01% | 928 |
|
|
2023
Q1 | $7.36K | Buy |
+832
| New | +$7.36K | ﹤0.01% | 1045 |
|
|
2022
Q3 | – | Sell |
-12,357
| Closed | -$93K | – | 1245 |
|
|
2022
Q2 | $93K | Buy |
+12,357
| New | +$93K | ﹤0.01% | 1013 |
|